SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-17-000896
Filing Date
2017-11-08
Accepted
2017-11-08 15:51:26
Documents
2
Group Members
ORBIMED CAPITAL GP V LLCORBIMED GLOBAL HEALTHCARE GP LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss66735_sc13da.htm SC 13D/A 144847
2 JOINT FILING AGREEMENT ss66735_ex9901.htm EX-99.1 13765
  Complete submission text file 0000947871-17-000896.txt   160239
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89486 | Film No.: 171186467
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences